2025 annual financial data
Amneal Pharmaceuticals 2025 Operating margin
Amneal Pharmaceuticals 2025 operating margin with verified reported values.
Direct answer
Operating margin was 14.02%.
Operating income was 423,090,000 USD and net income was 72,057,000 USD.
Operating cash flow was 339,992,000 USD.
Get free Amneal Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,018,760,000 USD
- Operating income
- 423,090,000 USD
- Net income
- 72,057,000 USD
- Operating cash flow
- 339,992,000 USD